3450. Deputy Richard Boyd Barrett asked the Minister for Health whether any interim tucatinib access arrangements are being considered while the tucatinib metastatic cancer medicine reimbursement process is ongoing; and if she will make a statement on the matter. [60491/26]

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.